Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Do Your Genes Put You at a Higher Risk of Developing Mesothelioma
Consortium for the Sharing of Germ Line DNA and Tissue From Subjects With Mesothelioma
Status: Enrolling
Updated:  11/3/2017
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Do Your Genes Put You at a Higher Risk of Developing Mesothelioma
Consortium for the Sharing of Germ Line DNA and Tissue From Subjects With Mesothelioma
Status: Enrolling
Updated: 11/3/2017
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Do Your Genes Put You at a Higher Risk of Developing Mesothelioma
Consortium for the Sharing of Germ Line DNA and Tissue From Subjects With Mesothelioma
Status: Enrolling
Updated:  11/3/2017
Wake Forest University Health Sciences
mi
from
Winston-Salem, NC
Do Your Genes Put You at a Higher Risk of Developing Mesothelioma
Consortium for the Sharing of Germ Line DNA and Tissue From Subjects With Mesothelioma
Status: Enrolling
Updated: 11/3/2017
Wake Forest University Health Sciences
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Do Your Genes Put You at a Higher Risk of Developing Mesothelioma
Consortium for the Sharing of Germ Line DNA and Tissue From Subjects With Mesothelioma
Status: Enrolling
Updated:  11/3/2017
Univ of Pennsylvania
mi
from
Philadelphia, PA
Do Your Genes Put You at a Higher Risk of Developing Mesothelioma
Consortium for the Sharing of Germ Line DNA and Tissue From Subjects With Mesothelioma
Status: Enrolling
Updated: 11/3/2017
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Acupuncture for Aromatase Inhibitor Induced Joint Pain
Pilot Study on the Effect of Acupuncture on Joint Pain Induced by Aromatase Inhibitors in Breast Cancer Patients
Status: Enrolling
Updated:  11/3/2017
Columbia University
mi
from
New York, NY
Acupuncture for Aromatase Inhibitor Induced Joint Pain
Pilot Study on the Effect of Acupuncture on Joint Pain Induced by Aromatase Inhibitors in Breast Cancer Patients
Status: Enrolling
Updated: 11/3/2017
Columbia University
mi
from
New York, NY
Click here to add this to my saved trials
Flu Vaccine in Preventing Influenza Infection in Healthy Volunteers and in Patients Who Have Undergone Stem Cell Transplant
Influenza Specific Humoral and Cellular Immunity After Vaccination in Recipients of Allogeneic and Autologous Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated:  11/3/2017
City of Hope Comprehensive Cancer Center
mi
from
Duarte, CA
Flu Vaccine in Preventing Influenza Infection in Healthy Volunteers and in Patients Who Have Undergone Stem Cell Transplant
Influenza Specific Humoral and Cellular Immunity After Vaccination in Recipients of Allogeneic and Autologous Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated: 11/3/2017
City of Hope Comprehensive Cancer Center
mi
from
Duarte, CA
Click here to add this to my saved trials
Flu Vaccine in Preventing Influenza Infection in Healthy Volunteers and in Patients Who Have Undergone Stem Cell Transplant
Influenza Specific Humoral and Cellular Immunity After Vaccination in Recipients of Allogeneic and Autologous Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated:  11/3/2017
City of Hope Medical Group Inc
mi
from
Pasadena, CA
Flu Vaccine in Preventing Influenza Infection in Healthy Volunteers and in Patients Who Have Undergone Stem Cell Transplant
Influenza Specific Humoral and Cellular Immunity After Vaccination in Recipients of Allogeneic and Autologous Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated: 11/3/2017
City of Hope Medical Group Inc
mi
from
Pasadena, CA
Click here to add this to my saved trials
Understanding Decision Making Processes for Undergoing Genetic Testing Among Women With Newly Diagnosed Breast Cancer
Understanding Decision Making Processes for Undergoing Genetic Testing Among Women With Newly Diagnosed Breast Cancer
Status: Enrolling
Updated:  11/6/2017
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Understanding Decision Making Processes for Undergoing Genetic Testing Among Women With Newly Diagnosed Breast Cancer
Understanding Decision Making Processes for Undergoing Genetic Testing Among Women With Newly Diagnosed Breast Cancer
Status: Enrolling
Updated: 11/6/2017
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Biospecimens for Identification of Diseases of the Pancreas.
Biospecimens for the Early Detection, Prevention, Diagnosis and Treatment of Diseases of the Pancreas.
Status: Enrolling
Updated:  11/6/2017
Univerisity of Michigan
mi
from
Ann Arbor, MI
Biospecimens for Identification of Diseases of the Pancreas.
Biospecimens for the Early Detection, Prevention, Diagnosis and Treatment of Diseases of the Pancreas.
Status: Enrolling
Updated: 11/6/2017
Univerisity of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Vismodegib in Treating Patients With Basal Cell Carcinoma (BCC)
A Pilot Study to Investigate the Off Label Use of Vismodegib as an Adjuvant to Surgery for Basal Cell Carcinoma Tumors (BCCs)
Status: Enrolling
Updated:  11/6/2017
Stanford University
mi
from
Stanford, CA
Vismodegib in Treating Patients With Basal Cell Carcinoma (BCC)
A Pilot Study to Investigate the Off Label Use of Vismodegib as an Adjuvant to Surgery for Basal Cell Carcinoma Tumors (BCCs)
Status: Enrolling
Updated: 11/6/2017
Stanford University
mi
from
Stanford, CA
Click here to add this to my saved trials
GI SPORE Colon Biosample Protocol
Biospecimens for the Diagnosis, Treatment and Prevention of Colorectal Cancer
Status: Enrolling
Updated:  11/6/2017
University of Michigan
mi
from
Ann Arbor, MI
GI SPORE Colon Biosample Protocol
Biospecimens for the Diagnosis, Treatment and Prevention of Colorectal Cancer
Status: Enrolling
Updated: 11/6/2017
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
RAD001 and Bicalutamide for Androgen Independent Prostate Cancer
A Phase II Trial of RAD001 and Bicalutamide for Androgen Independent Prostate Cancer
Status: Enrolling
Updated:  11/6/2017
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
RAD001 and Bicalutamide for Androgen Independent Prostate Cancer
A Phase II Trial of RAD001 and Bicalutamide for Androgen Independent Prostate Cancer
Status: Enrolling
Updated: 11/6/2017
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
RAD001 and Bicalutamide for Androgen Independent Prostate Cancer
A Phase II Trial of RAD001 and Bicalutamide for Androgen Independent Prostate Cancer
Status: Enrolling
Updated:  11/6/2017
Dana-Farber Cancer Institute
mi
from
Boston, MA
RAD001 and Bicalutamide for Androgen Independent Prostate Cancer
A Phase II Trial of RAD001 and Bicalutamide for Androgen Independent Prostate Cancer
Status: Enrolling
Updated: 11/6/2017
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Tretinoin Plus Interferon Alfa in Treating Patients With Metastatic Kidney Cancer
Phase II Trial of Atragen and Interferon Alfa-2b in Patients With Advanced Renal Cell Carcinoma
Status: Enrolling
Updated:  11/6/2017
New York Weill Cornell Cancer Center at Cornell University
mi
from
New York, NY
Tretinoin Plus Interferon Alfa in Treating Patients With Metastatic Kidney Cancer
Phase II Trial of Atragen and Interferon Alfa-2b in Patients With Advanced Renal Cell Carcinoma
Status: Enrolling
Updated: 11/6/2017
New York Weill Cornell Cancer Center at Cornell University
mi
from
New York, NY
Click here to add this to my saved trials
Tretinoin Plus Interferon Alfa in Treating Patients With Metastatic Kidney Cancer
Phase II Trial of Atragen and Interferon Alfa-2b in Patients With Advanced Renal Cell Carcinoma
Status: Enrolling
Updated:  11/6/2017
Herbert Irving Comprehensive Cancer Center of Columbia University
mi
from
New York, NY
Tretinoin Plus Interferon Alfa in Treating Patients With Metastatic Kidney Cancer
Phase II Trial of Atragen and Interferon Alfa-2b in Patients With Advanced Renal Cell Carcinoma
Status: Enrolling
Updated: 11/6/2017
Herbert Irving Comprehensive Cancer Center of Columbia University
mi
from
New York, NY
Click here to add this to my saved trials
Ultrasound-Guided Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer Previously Treated With External-Beam Radiation Therapy
A Prospective Phase II Trial of Transperineal Ultrasound-Guided Brachytherapy for Locally Recurrent Prostate Adenocarcinoma Following External Beam Radiotherapy
Status: Enrolling
Updated:  11/7/2017
Arizona Oncology Services Foundation
mi
from
Phoenix, AZ
Ultrasound-Guided Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer Previously Treated With External-Beam Radiation Therapy
A Prospective Phase II Trial of Transperineal Ultrasound-Guided Brachytherapy for Locally Recurrent Prostate Adenocarcinoma Following External Beam Radiotherapy
Status: Enrolling
Updated: 11/7/2017
Arizona Oncology Services Foundation
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Ultrasound-Guided Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer Previously Treated With External-Beam Radiation Therapy
A Prospective Phase II Trial of Transperineal Ultrasound-Guided Brachytherapy for Locally Recurrent Prostate Adenocarcinoma Following External Beam Radiotherapy
Status: Enrolling
Updated:  11/7/2017
California Cancer Center - Woodward Park Office
mi
from
Fresno, CA
Ultrasound-Guided Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer Previously Treated With External-Beam Radiation Therapy
A Prospective Phase II Trial of Transperineal Ultrasound-Guided Brachytherapy for Locally Recurrent Prostate Adenocarcinoma Following External Beam Radiotherapy
Status: Enrolling
Updated: 11/7/2017
California Cancer Center - Woodward Park Office
mi
from
Fresno, CA
Click here to add this to my saved trials
Ultrasound-Guided Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer Previously Treated With External-Beam Radiation Therapy
A Prospective Phase II Trial of Transperineal Ultrasound-Guided Brachytherapy for Locally Recurrent Prostate Adenocarcinoma Following External Beam Radiotherapy
Status: Enrolling
Updated:  11/7/2017
Winship Cancer Institute at Emory University
mi
from
Atlanta, GA
Ultrasound-Guided Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer Previously Treated With External-Beam Radiation Therapy
A Prospective Phase II Trial of Transperineal Ultrasound-Guided Brachytherapy for Locally Recurrent Prostate Adenocarcinoma Following External Beam Radiotherapy
Status: Enrolling
Updated: 11/7/2017
Winship Cancer Institute at Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Ultrasound-Guided Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer Previously Treated With External-Beam Radiation Therapy
A Prospective Phase II Trial of Transperineal Ultrasound-Guided Brachytherapy for Locally Recurrent Prostate Adenocarcinoma Following External Beam Radiotherapy
Status: Enrolling
Updated:  11/7/2017
Cancer Institute at St. John's Hospital
mi
from
Springfield, IL
Ultrasound-Guided Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer Previously Treated With External-Beam Radiation Therapy
A Prospective Phase II Trial of Transperineal Ultrasound-Guided Brachytherapy for Locally Recurrent Prostate Adenocarcinoma Following External Beam Radiotherapy
Status: Enrolling
Updated: 11/7/2017
Cancer Institute at St. John's Hospital
mi
from
Springfield, IL
Click here to add this to my saved trials
Ultrasound-Guided Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer Previously Treated With External-Beam Radiation Therapy
A Prospective Phase II Trial of Transperineal Ultrasound-Guided Brachytherapy for Locally Recurrent Prostate Adenocarcinoma Following External Beam Radiotherapy
Status: Enrolling
Updated:  11/7/2017
Siteman Cancer Center at Barnes-Jewish St. Peters Hospital - St. Peters
mi
from
Saint Peters, MO
Ultrasound-Guided Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer Previously Treated With External-Beam Radiation Therapy
A Prospective Phase II Trial of Transperineal Ultrasound-Guided Brachytherapy for Locally Recurrent Prostate Adenocarcinoma Following External Beam Radiotherapy
Status: Enrolling
Updated: 11/7/2017
Siteman Cancer Center at Barnes-Jewish St. Peters Hospital - St. Peters
mi
from
Saint Peters, MO
Click here to add this to my saved trials
Ultrasound-Guided Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer Previously Treated With External-Beam Radiation Therapy
A Prospective Phase II Trial of Transperineal Ultrasound-Guided Brachytherapy for Locally Recurrent Prostate Adenocarcinoma Following External Beam Radiotherapy
Status: Enrolling
Updated:  11/7/2017
McDowell Cancer Center at Akron General Medical Center
mi
from
Akron, OH
Ultrasound-Guided Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer Previously Treated With External-Beam Radiation Therapy
A Prospective Phase II Trial of Transperineal Ultrasound-Guided Brachytherapy for Locally Recurrent Prostate Adenocarcinoma Following External Beam Radiotherapy
Status: Enrolling
Updated: 11/7/2017
McDowell Cancer Center at Akron General Medical Center
mi
from
Akron, OH
Click here to add this to my saved trials
Ultrasound-Guided Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer Previously Treated With External-Beam Radiation Therapy
A Prospective Phase II Trial of Transperineal Ultrasound-Guided Brachytherapy for Locally Recurrent Prostate Adenocarcinoma Following External Beam Radiotherapy
Status: Enrolling
Updated:  11/7/2017
Robinson Radiation Oncology
mi
from
Ravenna, OH
Ultrasound-Guided Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer Previously Treated With External-Beam Radiation Therapy
A Prospective Phase II Trial of Transperineal Ultrasound-Guided Brachytherapy for Locally Recurrent Prostate Adenocarcinoma Following External Beam Radiotherapy
Status: Enrolling
Updated: 11/7/2017
Robinson Radiation Oncology
mi
from
Ravenna, OH
Click here to add this to my saved trials
Ultrasound-Guided Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer Previously Treated With External-Beam Radiation Therapy
A Prospective Phase II Trial of Transperineal Ultrasound-Guided Brachytherapy for Locally Recurrent Prostate Adenocarcinoma Following External Beam Radiotherapy
Status: Enrolling
Updated:  11/7/2017
Flower Hospital Cancer Center
mi
from
Sylvania, OH
Ultrasound-Guided Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer Previously Treated With External-Beam Radiation Therapy
A Prospective Phase II Trial of Transperineal Ultrasound-Guided Brachytherapy for Locally Recurrent Prostate Adenocarcinoma Following External Beam Radiotherapy
Status: Enrolling
Updated: 11/7/2017
Flower Hospital Cancer Center
mi
from
Sylvania, OH
Click here to add this to my saved trials
Ultrasound-Guided Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer Previously Treated With External-Beam Radiation Therapy
A Prospective Phase II Trial of Transperineal Ultrasound-Guided Brachytherapy for Locally Recurrent Prostate Adenocarcinoma Following External Beam Radiotherapy
Status: Enrolling
Updated:  11/7/2017
Kimmel Cancer Center at Thomas Jefferson University - Philadelphia
mi
from
Philadelphia, PA
Ultrasound-Guided Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer Previously Treated With External-Beam Radiation Therapy
A Prospective Phase II Trial of Transperineal Ultrasound-Guided Brachytherapy for Locally Recurrent Prostate Adenocarcinoma Following External Beam Radiotherapy
Status: Enrolling
Updated: 11/7/2017
Kimmel Cancer Center at Thomas Jefferson University - Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Ultrasound-Guided Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer Previously Treated With External-Beam Radiation Therapy
A Prospective Phase II Trial of Transperineal Ultrasound-Guided Brachytherapy for Locally Recurrent Prostate Adenocarcinoma Following External Beam Radiotherapy
Status: Enrolling
Updated:  11/7/2017
Vince Lombardi Cancer Clinic at Aurora St. Luke's Medical Center
mi
from
Milwaukee, WI
Ultrasound-Guided Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer Previously Treated With External-Beam Radiation Therapy
A Prospective Phase II Trial of Transperineal Ultrasound-Guided Brachytherapy for Locally Recurrent Prostate Adenocarcinoma Following External Beam Radiotherapy
Status: Enrolling
Updated: 11/7/2017
Vince Lombardi Cancer Clinic at Aurora St. Luke's Medical Center
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Ultrasound-Guided Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer Previously Treated With External-Beam Radiation Therapy
A Prospective Phase II Trial of Transperineal Ultrasound-Guided Brachytherapy for Locally Recurrent Prostate Adenocarcinoma Following External Beam Radiotherapy
Status: Enrolling
Updated:  11/7/2017
West Allis Memorial Hospital
mi
from
West Allis, WI
Ultrasound-Guided Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer Previously Treated With External-Beam Radiation Therapy
A Prospective Phase II Trial of Transperineal Ultrasound-Guided Brachytherapy for Locally Recurrent Prostate Adenocarcinoma Following External Beam Radiotherapy
Status: Enrolling
Updated: 11/7/2017
West Allis Memorial Hospital
mi
from
West Allis, WI
Click here to add this to my saved trials
Ultrasound-Guided Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer Previously Treated With External-Beam Radiation Therapy
A Prospective Phase II Trial of Transperineal Ultrasound-Guided Brachytherapy for Locally Recurrent Prostate Adenocarcinoma Following External Beam Radiotherapy
Status: Enrolling
Updated:  11/7/2017
University of Colorado Cancer Center at UC Health Sciences Center
mi
from
Aurora, CO
Ultrasound-Guided Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer Previously Treated With External-Beam Radiation Therapy
A Prospective Phase II Trial of Transperineal Ultrasound-Guided Brachytherapy for Locally Recurrent Prostate Adenocarcinoma Following External Beam Radiotherapy
Status: Enrolling
Updated: 11/7/2017
University of Colorado Cancer Center at UC Health Sciences Center
mi
from
Aurora, CO
Click here to add this to my saved trials
Ultrasound-Guided Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer Previously Treated With External-Beam Radiation Therapy
A Prospective Phase II Trial of Transperineal Ultrasound-Guided Brachytherapy for Locally Recurrent Prostate Adenocarcinoma Following External Beam Radiotherapy
Status: Enrolling
Updated:  11/7/2017
Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis
mi
from
Saint Louis, MO
Ultrasound-Guided Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer Previously Treated With External-Beam Radiation Therapy
A Prospective Phase II Trial of Transperineal Ultrasound-Guided Brachytherapy for Locally Recurrent Prostate Adenocarcinoma Following External Beam Radiotherapy
Status: Enrolling
Updated: 11/7/2017
Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Ultrasound-Guided Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer Previously Treated With External-Beam Radiation Therapy
A Prospective Phase II Trial of Transperineal Ultrasound-Guided Brachytherapy for Locally Recurrent Prostate Adenocarcinoma Following External Beam Radiotherapy
Status: Enrolling
Updated:  11/7/2017
Cross Cancer Institute at University of Alberta
mi
from
Edmonton,
Ultrasound-Guided Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer Previously Treated With External-Beam Radiation Therapy
A Prospective Phase II Trial of Transperineal Ultrasound-Guided Brachytherapy for Locally Recurrent Prostate Adenocarcinoma Following External Beam Radiotherapy
Status: Enrolling
Updated: 11/7/2017
Cross Cancer Institute at University of Alberta
mi
from
Edmonton,
Click here to add this to my saved trials
Development of Early Detection Signs for Gastrointestinal Cancer
Investigation of the Immune Response to Gastrointestinal Tumors and Development of Novel Biomarkers for the Presence of Gastrointestinal Cancer
Status: Enrolling
Updated:  11/7/2017
University of Pittsburgh Cancer Institute
mi
from
Pittsburgh, PA
Development of Early Detection Signs for Gastrointestinal Cancer
Investigation of the Immune Response to Gastrointestinal Tumors and Development of Novel Biomarkers for the Presence of Gastrointestinal Cancer
Status: Enrolling
Updated: 11/7/2017
University of Pittsburgh Cancer Institute
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
A Study of the GSK MEK Inhibitor GSK1120212 and Everolimus in Cancer Subjects
An Open-Label, Dose-Escalation, Phase IB II Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of the MEK Inhibitor GSK1120212 in Combination With Oral Everolimus in Subjects With Solid Tumors
Status: Enrolling
Updated:  11/7/2017
GSK Investigational Site
mi
from
Nashville, TN
A Study of the GSK MEK Inhibitor GSK1120212 and Everolimus in Cancer Subjects
An Open-Label, Dose-Escalation, Phase IB II Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of the MEK Inhibitor GSK1120212 in Combination With Oral Everolimus in Subjects With Solid Tumors
Status: Enrolling
Updated: 11/7/2017
GSK Investigational Site
mi
from
Nashville, TN
Click here to add this to my saved trials
A Study of the GSK MEK Inhibitor GSK1120212 and Everolimus in Cancer Subjects
An Open-Label, Dose-Escalation, Phase IB II Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of the MEK Inhibitor GSK1120212 in Combination With Oral Everolimus in Subjects With Solid Tumors
Status: Enrolling
Updated:  11/7/2017
GSK Investigational Site
mi
from
San Antonio, TX
A Study of the GSK MEK Inhibitor GSK1120212 and Everolimus in Cancer Subjects
An Open-Label, Dose-Escalation, Phase IB II Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of the MEK Inhibitor GSK1120212 in Combination With Oral Everolimus in Subjects With Solid Tumors
Status: Enrolling
Updated: 11/7/2017
GSK Investigational Site
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Study of the GSK MEK Inhibitor GSK1120212 and Everolimus in Cancer Subjects
An Open-Label, Dose-Escalation, Phase IB II Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of the MEK Inhibitor GSK1120212 in Combination With Oral Everolimus in Subjects With Solid Tumors
Status: Enrolling
Updated:  11/7/2017
GSK Investigational Site
mi
from
Paris Cedex 20,
A Study of the GSK MEK Inhibitor GSK1120212 and Everolimus in Cancer Subjects
An Open-Label, Dose-Escalation, Phase IB II Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of the MEK Inhibitor GSK1120212 in Combination With Oral Everolimus in Subjects With Solid Tumors
Status: Enrolling
Updated: 11/7/2017
GSK Investigational Site
mi
from
Paris Cedex 20,
Click here to add this to my saved trials
CART19 to Treat B-Cell Leukemia or Lymphoma That Are Resistant or Refractory to Chemotherapy
Pilot Study of Redirected Autologous T-cells Engineered to Contain Anti-CD19 Attached to TCR and 4-1BB Signaling Domains in Patient With Chemotherapy Resistant or Refractory CD19+ Leukemia and Lymphoma
Status: Enrolling
Updated:  11/7/2017
Abramson Cancer Center of the University of Pennsylvania
mi
from
Philadelphia, PA
CART19 to Treat B-Cell Leukemia or Lymphoma That Are Resistant or Refractory to Chemotherapy
Pilot Study of Redirected Autologous T-cells Engineered to Contain Anti-CD19 Attached to TCR and 4-1BB Signaling Domains in Patient With Chemotherapy Resistant or Refractory CD19+ Leukemia and Lymphoma
Status: Enrolling
Updated: 11/7/2017
Abramson Cancer Center of the University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron Overload
Deferasirox Treatment and Labile Plasma Iron in Iron Overloaded Patients Who Have Undergone Allogeneic Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated:  11/7/2017
City of Hope
mi
from
Duarte, CA
Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron Overload
Deferasirox Treatment and Labile Plasma Iron in Iron Overloaded Patients Who Have Undergone Allogeneic Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated: 11/7/2017
City of Hope
mi
from
Duarte, CA
Click here to add this to my saved trials
Pilot Indocyanine Green Imaging for Mapping of Arm Draining Lymphatics & Nodes in Breast Cancer
A Pilot Study to Assess the Utility of Indocyanine Green™ (IC-GREEN™) SPY Imaging in the Mapping of Arm Draining Lymphatics and Nodes During Sentinel Node Resection With or Without Axillary Dissection in Breast Cancer
Status: Enrolling
Updated:  11/7/2017
Stanford University School of Medicine
mi
from
Stanford, CA
Pilot Indocyanine Green Imaging for Mapping of Arm Draining Lymphatics & Nodes in Breast Cancer
A Pilot Study to Assess the Utility of Indocyanine Green™ (IC-GREEN™) SPY Imaging in the Mapping of Arm Draining Lymphatics and Nodes During Sentinel Node Resection With or Without Axillary Dissection in Breast Cancer
Status: Enrolling
Updated: 11/7/2017
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
Next-generation Sequencing of Small Cell Lung Cancer to Identify Actionable Targets for Treatment
Next-generation Sequencing of Small Cell Lung Cancer to Identify Actionable Targets for Treatment
Status: Enrolling
Updated:  11/7/2017
Cancer Treatment Center of America @ Western Regional Medical Center
mi
from
Goodyear, AZ
Next-generation Sequencing of Small Cell Lung Cancer to Identify Actionable Targets for Treatment
Next-generation Sequencing of Small Cell Lung Cancer to Identify Actionable Targets for Treatment
Status: Enrolling
Updated: 11/7/2017
Cancer Treatment Center of America @ Western Regional Medical Center
mi
from
Goodyear, AZ
Click here to add this to my saved trials
Carbon-11 Labeled Sarcosine in Prostate Cancer
Biodistribution and Mechanism of Action of the 11C-labeled PET Tracer Sarcosine in Patients With Prostate Cancer as Well as Radiation Dosimetry, Plasma Pharmacokinetics and Biodistribution in Healthy Volunteers
Status: Enrolling
Updated:  11/7/2017
University of Michigan Health Systems
mi
from
Ann Arbor, MI
Carbon-11 Labeled Sarcosine in Prostate Cancer
Biodistribution and Mechanism of Action of the 11C-labeled PET Tracer Sarcosine in Patients With Prostate Cancer as Well as Radiation Dosimetry, Plasma Pharmacokinetics and Biodistribution in Healthy Volunteers
Status: Enrolling
Updated: 11/7/2017
University of Michigan Health Systems
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Alisertib, Abiraterone Acetate and Prednisone in Treating Patients With Hormone-Resistant Prostate Cancer
A Phase I/II Study of Alisertib in Combination With Abiraterone and Prednisone for Patients With Castration-Resistant Prostate Cancer After Progression on Abiraterone
Status: Enrolling
Updated:  11/8/2017
Thomas Jefferson University
mi
from
Philadelphia, PA
Alisertib, Abiraterone Acetate and Prednisone in Treating Patients With Hormone-Resistant Prostate Cancer
A Phase I/II Study of Alisertib in Combination With Abiraterone and Prednisone for Patients With Castration-Resistant Prostate Cancer After Progression on Abiraterone
Status: Enrolling
Updated: 11/8/2017
Thomas Jefferson University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Phase II Study of GSK1363089 (Formerly XL880) for Papillary Renal-Cell Carcinoma (PRC)
A Phase II Study of the c-MET RTK Inhibitor XL880 in Subjects With Papillary Renal-Cell Carcinoma
Status: Enrolling
Updated:  11/8/2017
GSK Investigational Site
mi
from
Greenbrae, CA
A Phase II Study of GSK1363089 (Formerly XL880) for Papillary Renal-Cell Carcinoma (PRC)
A Phase II Study of the c-MET RTK Inhibitor XL880 in Subjects With Papillary Renal-Cell Carcinoma
Status: Enrolling
Updated: 11/8/2017
GSK Investigational Site
mi
from
Greenbrae, CA
Click here to add this to my saved trials
A Phase II Study of GSK1363089 (Formerly XL880) for Papillary Renal-Cell Carcinoma (PRC)
A Phase II Study of the c-MET RTK Inhibitor XL880 in Subjects With Papillary Renal-Cell Carcinoma
Status: Enrolling
Updated:  11/8/2017
GSK Investigational Site
mi
from
San Francisco, CA
A Phase II Study of GSK1363089 (Formerly XL880) for Papillary Renal-Cell Carcinoma (PRC)
A Phase II Study of the c-MET RTK Inhibitor XL880 in Subjects With Papillary Renal-Cell Carcinoma
Status: Enrolling
Updated: 11/8/2017
GSK Investigational Site
mi
from
San Francisco, CA
Click here to add this to my saved trials
A Phase II Study of GSK1363089 (Formerly XL880) for Papillary Renal-Cell Carcinoma (PRC)
A Phase II Study of the c-MET RTK Inhibitor XL880 in Subjects With Papillary Renal-Cell Carcinoma
Status: Enrolling
Updated:  11/8/2017
GSK Investigational Site
mi
from
Indianapolis, IN
A Phase II Study of GSK1363089 (Formerly XL880) for Papillary Renal-Cell Carcinoma (PRC)
A Phase II Study of the c-MET RTK Inhibitor XL880 in Subjects With Papillary Renal-Cell Carcinoma
Status: Enrolling
Updated: 11/8/2017
GSK Investigational Site
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Phase II Study of GSK1363089 (Formerly XL880) for Papillary Renal-Cell Carcinoma (PRC)
A Phase II Study of the c-MET RTK Inhibitor XL880 in Subjects With Papillary Renal-Cell Carcinoma
Status: Enrolling
Updated:  11/8/2017
GSK Investigational Site
mi
from
Bethesda, MD
A Phase II Study of GSK1363089 (Formerly XL880) for Papillary Renal-Cell Carcinoma (PRC)
A Phase II Study of the c-MET RTK Inhibitor XL880 in Subjects With Papillary Renal-Cell Carcinoma
Status: Enrolling
Updated: 11/8/2017
GSK Investigational Site
mi
from
Bethesda, MD
Click here to add this to my saved trials
A Phase II Study of GSK1363089 (Formerly XL880) for Papillary Renal-Cell Carcinoma (PRC)
A Phase II Study of the c-MET RTK Inhibitor XL880 in Subjects With Papillary Renal-Cell Carcinoma
Status: Enrolling
Updated:  11/8/2017
GSK Investigational Site
mi
from
Boston, MA
A Phase II Study of GSK1363089 (Formerly XL880) for Papillary Renal-Cell Carcinoma (PRC)
A Phase II Study of the c-MET RTK Inhibitor XL880 in Subjects With Papillary Renal-Cell Carcinoma
Status: Enrolling
Updated: 11/8/2017
GSK Investigational Site
mi
from
Boston, MA
Click here to add this to my saved trials
A Phase II Study of GSK1363089 (Formerly XL880) for Papillary Renal-Cell Carcinoma (PRC)
A Phase II Study of the c-MET RTK Inhibitor XL880 in Subjects With Papillary Renal-Cell Carcinoma
Status: Enrolling
Updated:  11/8/2017
GSK Investigational Site
mi
from
Detroit, MI
A Phase II Study of GSK1363089 (Formerly XL880) for Papillary Renal-Cell Carcinoma (PRC)
A Phase II Study of the c-MET RTK Inhibitor XL880 in Subjects With Papillary Renal-Cell Carcinoma
Status: Enrolling
Updated: 11/8/2017
GSK Investigational Site
mi
from
Detroit, MI
Click here to add this to my saved trials
A Phase II Study of GSK1363089 (Formerly XL880) for Papillary Renal-Cell Carcinoma (PRC)
A Phase II Study of the c-MET RTK Inhibitor XL880 in Subjects With Papillary Renal-Cell Carcinoma
Status: Enrolling
Updated:  11/8/2017
GSK Investigational Site
mi
from
New Brunswick, NJ
A Phase II Study of GSK1363089 (Formerly XL880) for Papillary Renal-Cell Carcinoma (PRC)
A Phase II Study of the c-MET RTK Inhibitor XL880 in Subjects With Papillary Renal-Cell Carcinoma
Status: Enrolling
Updated: 11/8/2017
GSK Investigational Site
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
A Phase II Study of GSK1363089 (Formerly XL880) for Papillary Renal-Cell Carcinoma (PRC)
A Phase II Study of the c-MET RTK Inhibitor XL880 in Subjects With Papillary Renal-Cell Carcinoma
Status: Enrolling
Updated:  11/8/2017
GSK Investigational Site
mi
from
Cleveland, OH
A Phase II Study of GSK1363089 (Formerly XL880) for Papillary Renal-Cell Carcinoma (PRC)
A Phase II Study of the c-MET RTK Inhibitor XL880 in Subjects With Papillary Renal-Cell Carcinoma
Status: Enrolling
Updated: 11/8/2017
GSK Investigational Site
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Phase II Study of GSK1363089 (Formerly XL880) for Papillary Renal-Cell Carcinoma (PRC)
A Phase II Study of the c-MET RTK Inhibitor XL880 in Subjects With Papillary Renal-Cell Carcinoma
Status: Enrolling
Updated:  11/8/2017
GSK Investigational Site
mi
from
Philadelphia, PA
A Phase II Study of GSK1363089 (Formerly XL880) for Papillary Renal-Cell Carcinoma (PRC)
A Phase II Study of the c-MET RTK Inhibitor XL880 in Subjects With Papillary Renal-Cell Carcinoma
Status: Enrolling
Updated: 11/8/2017
GSK Investigational Site
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Phase II Study of GSK1363089 (Formerly XL880) for Papillary Renal-Cell Carcinoma (PRC)
A Phase II Study of the c-MET RTK Inhibitor XL880 in Subjects With Papillary Renal-Cell Carcinoma
Status: Enrolling
Updated:  11/8/2017
GSK Investigational Site
mi
from
Nashville, TN
A Phase II Study of GSK1363089 (Formerly XL880) for Papillary Renal-Cell Carcinoma (PRC)
A Phase II Study of the c-MET RTK Inhibitor XL880 in Subjects With Papillary Renal-Cell Carcinoma
Status: Enrolling
Updated: 11/8/2017
GSK Investigational Site
mi
from
Nashville, TN
Click here to add this to my saved trials
A Phase II Study of GSK1363089 (Formerly XL880) for Papillary Renal-Cell Carcinoma (PRC)
A Phase II Study of the c-MET RTK Inhibitor XL880 in Subjects With Papillary Renal-Cell Carcinoma
Status: Enrolling
Updated:  11/8/2017
GSK Investigational Site
mi
from
San Antonio, TX
A Phase II Study of GSK1363089 (Formerly XL880) for Papillary Renal-Cell Carcinoma (PRC)
A Phase II Study of the c-MET RTK Inhibitor XL880 in Subjects With Papillary Renal-Cell Carcinoma
Status: Enrolling
Updated: 11/8/2017
GSK Investigational Site
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Phase II Study of GSK1363089 (Formerly XL880) for Papillary Renal-Cell Carcinoma (PRC)
A Phase II Study of the c-MET RTK Inhibitor XL880 in Subjects With Papillary Renal-Cell Carcinoma
Status: Enrolling
Updated:  11/8/2017
GSK Investigational Site
mi
from
Stanford, CA
A Phase II Study of GSK1363089 (Formerly XL880) for Papillary Renal-Cell Carcinoma (PRC)
A Phase II Study of the c-MET RTK Inhibitor XL880 in Subjects With Papillary Renal-Cell Carcinoma
Status: Enrolling
Updated: 11/8/2017
GSK Investigational Site
mi
from
Stanford, CA
Click here to add this to my saved trials